<?xml version="1.0" encoding="UTF-8"?>
<feed xmlns="http://www.w3.org/2005/Atom" xmlns:dc="http://purl.org/dc/elements/1.1/">
  <title>DSpace Community:</title>
  <link rel="alternate" href="http://repository.usmf.md:80/handle/20.500.12710/254" />
  <subtitle />
  <id>http://repository.usmf.md:80/handle/20.500.12710/254</id>
  <updated>2026-06-05T02:09:30Z</updated>
  <dc:date>2026-06-05T02:09:30Z</dc:date>
  <entry>
    <title>Development and testing of a questionnaire: assessment of occupational risk factors in surgeons</title>
    <link rel="alternate" href="http://repository.usmf.md:80/handle/20.500.12710/33389" />
    <author>
      <name>Vîlcova, Ana</name>
    </author>
    <author>
      <name>Ferdohleb, Alexandru</name>
    </author>
    <author>
      <name>Spinei, Larisa</name>
    </author>
    <author>
      <name>Paraschiv, Angela</name>
    </author>
    <author>
      <name>Deleu, Raisa</name>
    </author>
    <author>
      <name>Ciobanu, Elena</name>
    </author>
    <id>http://repository.usmf.md:80/handle/20.500.12710/33389</id>
    <updated>2026-06-02T11:12:38Z</updated>
    <published>2026-01-01T00:00:00Z</published>
    <summary type="text">Title: Development and testing of a questionnaire: assessment of occupational risk factors in surgeons
Authors: Vîlcova, Ana; Ferdohleb, Alexandru; Spinei, Larisa; Paraschiv, Angela; Deleu, Raisa; Ciobanu, Elena
Abstract: Introduction. Surgery exposes professionals to significant physical and psychological risks, including intense exertion,&#xD;
prolonged static postures, and repetitive gestures, often leading to musculoskeletal pain. International studies report prevalence&#xD;
rates above 90%, linked to long procedures and poor ergonomics, alongside exposure to biological and chemical&#xD;
hazards, radiation, toxic smoke, and chronic stress. In the Republic of Moldova, occupational health in the medical sector is&#xD;
underexplored, with no tools tailored to surgeons. This study aims to develop and validate the first nationally standardized&#xD;
questionnaire to assess these risks and support public health policies.&#xD;
Material and methods. The study used a sequential mixed-methods design: a qualitative phase to identify domains and&#xD;
indicators, followed by a quantitative phase for psychometric testing. Four domains were defined: working conditions,&#xD;
occupational factors, general health, and psycho-emotional state. The questionnaire was refined from 70 to 47 items after&#xD;
expert review and validation, with internal consistency (Cronbach’s α) and content validity (I-CVI, modified Kappa) assessed.&#xD;
It was pre-tested on 52 surgeons, and data were analyzed using SPSS 27 (p&lt;0.05).&#xD;
Results. Content validation revealed S-CVI/Ave values ranging from 0.934 to 1.00 and S-CVI/UA values from 0.738 to 1.00,&#xD;
with all domains exceeding the accepted threshold for relevance and clarity, except for one domain, which fell slightly&#xD;
below the recommended level for unanimous agreement. I-CVI values ranged from 0.857 to 1.00 (relevance) and 0.847 to&#xD;
1.00 (clarity), while κ* indices were all rated as “excellent”. Based on expert feedback, 24 questions were revised and 15&#xD;
were removed. Overall internal consistency was very good (α = 0.808), with section values ranging from 0.769 to 0.864, the&#xD;
highest being for “Psycho-emotional state” (α = 0.864). The pre-test sample comprised 52 surgeons, mostly male (57.7%),&#xD;
with a mean age of 44.92 years, predominantly from urban areas (92.3%). Respondents generally found the questions clear&#xD;
but noted some lengthy formulations, repetitiveness, and sensitive items. These observations contributed to optimizing&#xD;
the final version of the instrument.&#xD;
Conclusions. The final questionnaire meets the initial theoretical dimensions and shows strong psychometric properties,&#xD;
with high validity and internal consistency. The tool is comparable to established instruments and suitable for assessing&#xD;
surgeons’ health and occupational risks, with potential for wider use.</summary>
    <dc:date>2026-01-01T00:00:00Z</dc:date>
  </entry>
  <entry>
    <title>From prolonged premature rupture of membranes to bronchopulmonary dysplasia: the role of chorioamnionitis in the respiratory outcomes of preterm infants</title>
    <link rel="alternate" href="http://repository.usmf.md:80/handle/20.500.12710/33388" />
    <author>
      <name>Dascaliuc, Liuba</name>
    </author>
    <author>
      <name>Crivceanscaia, Larisa</name>
    </author>
    <author>
      <name>Oclanschi, Ludmila</name>
    </author>
    <author>
      <name>Revenco, Ninel</name>
    </author>
    <author>
      <name>Cracea, Angela</name>
    </author>
    <author>
      <name>Sârbu, Zinaida</name>
    </author>
    <id>http://repository.usmf.md:80/handle/20.500.12710/33388</id>
    <updated>2026-06-02T10:39:12Z</updated>
    <published>2026-01-01T00:00:00Z</published>
    <summary type="text">Title: From prolonged premature rupture of membranes to bronchopulmonary dysplasia: the role of chorioamnionitis in the respiratory outcomes of preterm infants
Authors: Dascaliuc, Liuba; Crivceanscaia, Larisa; Oclanschi, Ludmila; Revenco, Ninel; Cracea, Angela; Sârbu, Zinaida
Abstract: Introduction. Prolonged premature rupture of membranes predisposes to intrauterine infection and chorioamnionitis,&#xD;
both of which have significant implications for neonatal outcomes. While chorioamnionitis has been linked to accelerated&#xD;
surfactant production and reduced respiratory distress syndrome, it is also associated with long-term pulmonary injury,&#xD;
including bronchopulmonary dysplasia and pulmonary hypertension. The objective of the study is to investigate the association&#xD;
between prolonged premature rupture of membranes, chorioamnionitis, and respiratory outcomes among preterm&#xD;
infants ≤34 weeks of gestation.&#xD;
Material and methods. A prospective cohort of 108 preterm infants admitted to the Neonatal Intensive Care Unit of the&#xD;
Mother and Child Institute, Chișinău, between October 2023 and July 2024, was divided into two groups: infants born to&#xD;
mothers with clinical/histological chorioamnionitis (n = 54) and controls (n = 54). Maternal risk factors, incidence of prolonged&#xD;
premature rupture of membranes incidence, Apgar scores, type and duration of respiratory support, and pulmonary&#xD;
complications were analyzed. Statistical significance was tested using chi-square and logistic regression.&#xD;
Results. Prolonged premature rupture of membranes was significantly more frequent in chorioamnionitis group (67% vs.&#xD;
22%, p&lt;0.001). Infants exposed to chorioamnionitis had lower 1-minute Apgar scores, greater need for invasive ventilation&#xD;
(5.9 ± 10.6 vs. 2.2 ± 4.8 days, p&lt;0.05), and prolonged hospitalization. BPD incidence was higher in the chorioamnionitis&#xD;
group (25.9% vs. 3.7%, p&lt;0.05). Mortality did not differ significantly between groups (27.8% vs. 22.2%).&#xD;
Conclusions. Prolonged premature rupture of membranes is strongly associated with chorioamnionitis, which in turn&#xD;
significantly increases the risk of long-term pulmonary complications in preterm infants. Early recognition of prolonged&#xD;
premature rupture of membranes, antibiotic prophylaxis, antenatal corticosteroids, and interdisciplinary obstetric–neonatal&#xD;
management are essential to reduce the burden of bronchopulmonary dysplasia.</summary>
    <dc:date>2026-01-01T00:00:00Z</dc:date>
  </entry>
  <entry>
    <title>Pharmacoresistant burning mouth syndrome: clinical patterns and treatment efficacy</title>
    <link rel="alternate" href="http://repository.usmf.md:80/handle/20.500.12710/33383" />
    <author>
      <name>Purice, Virgilia</name>
    </author>
    <author>
      <name>Purice, Vasile</name>
    </author>
    <author>
      <name>Bordeniuc, Gheorghe</name>
    </author>
    <author>
      <name>Lacusta, Victor</name>
    </author>
    <id>http://repository.usmf.md:80/handle/20.500.12710/33383</id>
    <updated>2026-05-30T11:27:44Z</updated>
    <published>2026-01-01T00:00:00Z</published>
    <summary type="text">Title: Pharmacoresistant burning mouth syndrome: clinical patterns and treatment efficacy
Authors: Purice, Virgilia; Purice, Vasile; Bordeniuc, Gheorghe; Lacusta, Victor
Abstract: Introduction. Burning mouth syndrome is a form of idiopathic orofacial pain, characterized by a persistent&#xD;
intraoral burning sensation or dysesthesia, in the absence of obvious causative lesions. The management of this&#xD;
condition remains difficult, due to the heterogeneity of the mechanisms involved, the variable therapeutic&#xD;
response and the significant impact on the quality of life.&#xD;
Aim: To describe the clinical and therapeutic profile of patients with burning mouth syndrome with poor&#xD;
pharmacological response (pharmacoresistance).&#xD;
Materials and methods: The study had an observational, descriptive, case series design, and included 20 patients&#xD;
with burning mouth syndrome. The duration of treatment, drug classes used, reported adverse reactions,&#xD;
percentage of pain reduction under pharmacotherapy, VAS scores and OHIP-14 score were analyzed. Absolute&#xD;
and relative frequencies were calculated for categorical variables, and mean and standard deviation, median,&#xD;
interquartile range, and minimum and maximum values were reported for numerical variables.&#xD;
Results. The group presented multiple drug class use, with benzodiazepines being administered to 95% of&#xD;
patients, antidepressants to 85%, and topical treatments to 70%. Treatment duration was 56.4 ± 13.8 months, with&#xD;
a median of 59 months. Pain reduction under pharmacotherapy was modest, with a mean of 25.8 ± 4.4%, and&#xD;
residual pain intensity remained high, with a mean VAS score of 5.92 ± 0.37. For OHIP-14, available in 19&#xD;
patients, the mean score was 28.8 ± 5.2. Tinnitus and vertigo were among the most frequently reported adverse&#xD;
reactions.&#xD;
Conclusions. The patients included in the study presented a profile characterized by long-term treatment,&#xD;
polypharmacotherapy, modest pain relief, persistence of pain symptoms, and significant impairment of oral&#xD;
quality of life. This picture reflects a limited therapeutic response and supports the need for a multimodal,&#xD;
individualized approach, with the integration of functional assessment and therapeutic tolerability.</summary>
    <dc:date>2026-01-01T00:00:00Z</dc:date>
  </entry>
  <entry>
    <title>Sindromul de gură arzândă farmacorezistent: tiparele clinice și eficiența tratamentului</title>
    <link rel="alternate" href="http://repository.usmf.md:80/handle/20.500.12710/33382" />
    <author>
      <name>Purice, Virgilia</name>
    </author>
    <author>
      <name>Purice, Vasile</name>
    </author>
    <author>
      <name>Bordeniuc, Gheorghe</name>
    </author>
    <author>
      <name>Lacusta, Victor</name>
    </author>
    <id>http://repository.usmf.md:80/handle/20.500.12710/33382</id>
    <updated>2026-05-30T11:23:07Z</updated>
    <published>2026-01-01T00:00:00Z</published>
    <summary type="text">Title: Sindromul de gură arzândă farmacorezistent: tiparele clinice și eficiența tratamentului
Authors: Purice, Virgilia; Purice, Vasile; Bordeniuc, Gheorghe; Lacusta, Victor
Abstract: Introducere. Sindromul de gură arzândă reprezintă o formă de durere orofacială idiopatică, caracterizată prin&#xD;
senzație intraorală persistentă de arsură sau disestezie, în absența unor leziuni cauzale evidente. Managementul&#xD;
acestei afecțiuni rămâne dificil, din cauza heterogenității mecanismelor implicate, a răspunsului terapeutic&#xD;
variabil și a impactului important asupra calității vieții.&#xD;
Scop: Descrierea profilului clinic și terapeutic al pacienților cu sindrom de gură arzândă cu răspuns farmacologic&#xD;
deficitar (farmacorezistență).&#xD;
Materiale și metode: Studiul a avut un design observațional, descriptiv, de tip serie de cazuri, și a inclus 20 de&#xD;
pacienți cu sindrom de gură arzândă. Au fost analizate durata tratamentului, clasele medicamentoase utilizate,&#xD;
reacțiile adverse raportate, procentul reducerii durerii sub farmacoterapie, scorurile VAS și scorul OHIP-14.&#xD;
Pentru variabilele categoriale au fost calculate frecvențele absolute și relative, iar pentru variabilele numerice au&#xD;
fost raportate media și deviația standard, mediana, intervalul intercuartilic și valorile minime și maxime.&#xD;
Rezultate. Lotul a prezentat utilizarea multiplă a claselor medicamentoase, benzodiazepinele fiind administrate&#xD;
la 95% dintre pacienți, antidepresantele la 85%, iar tratamentele topice la 70%. Durata tratamentului a fost de&#xD;
56,4 ± 13,8 luni, cu mediană 59 luni. Reducerea durerii sub farmacoterapie a fost modestă, media fiind de 25,8 ±&#xD;
4,4%, iar intensitatea durerii reziduale s-a menținut ridicată, cu un scor VAS mediu de 5,92 ± 0,37. Pentru OHIP14, disponibil la 19 pacienți, scorul mediu a fost de 28,8 ± 5,2. Tinitusul și vertijul s-au numărat printre cele mai&#xD;
frecvent raportate reacții adverse.&#xD;
Concluzii. Pacienții incluși în studiu au prezentat un profil caracterizat prin tratament de lungă durată,&#xD;
polifarmacoterapie, reducere modestă a durerii, persistența simptomatologiei algice și afectarea semnificativă a&#xD;
calității vieții orale. Acest tablou reflectă un răspuns terapeutic limitat și susține necesitatea unei abordări&#xD;
multimodale, individualizate, cu integrarea evaluării funcționale și a tolerabilității terapeutice.</summary>
    <dc:date>2026-01-01T00:00:00Z</dc:date>
  </entry>
</feed>

